Skip to content

NAMSW

NewAmsterdam Pharma Co. NV

NASDAQ · Healthcare · Biotechnology · NL

$11.00
−8.33%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
P/E 2026E
P/E 2027E
P/E 2028E
P/S forward
45.86x

Trailing multiples

Trailing twelve months

P/E TTM
PEG TTM
Price / book
1.99x
Price / sales
176.72x
Price / cash flow
-8.77x

Enterprise value

Enterprise value
$624.6M
EV / sales
87.72x
EV / EBITDA
-2.45x
EV / EBIT
-2.56x
Market cap
$1.3B

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026